June 4, 2009 - LifeSync Corp. this week said Florida Hospital in Orlando completed implementation of the LifeSync System throughout its Cardiovascular Institute for patients undergoing cardiovascular surgery.

June 4, 2009 - Lantheus Medical Imaging Inc. said today the company’s leading imaging agent, Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), was used in a recently completed five-year study examining appropriate treatment regimens for patients with type 2 diabetes and coronary artery disease.

June 3, 2009 – UltraSPECT said yesterday it will launch its Attenuation Correction/Scatter Correction (ACSC) package to its nuclear medicine image reconstruction products following the FDA clearance of the software package.

June 3, 2009 - The Chalk River Laboratories (CRL) nuclear reactor, which supplies about a third of the world’s medical isotopes, has been shut down since May 14 and is not expected to be back for at least three months, according to Atomic Energy of Canada Ltd. (AECL).

The reactor produces medical isotopes such as molybdenum-99 (Mo-99), which are used in diagnostic nuclear imaging scans.

The Ampronix’s Modalixx line is the first universal medical auto sync LCD solution for CRT monitor replacement, the company said. With inputs including 1-5 BNC and 15 pin D-Sub, Modalixx offers compatibility for an array of modality applications.

June 2, 2009 – During their report Friday at the 63rd Annual Meeting of the Society for Vascular Surgery, Seshadri Raju, M.D., FACS, and other researchers from the University of Mississippi in Jackson offered details about how many patients with severe symptoms of chronic venous insufficiency (CVI) often can be treated with newer, minimally invasive stent treatment without surgery.

June 2, 2009 - Transoma Medical Inc., manufacturer of Sleuth and Sleuth AT wireless, automated implantable cardiac monitoring (ICM) systems, received FDA 510(k) marketing clearance for its new data review feature, allowing clinicians to easily access up to 99 events stored on the patient’s Personal Diagnostic Manager (PDM).

June 2, 2009 - IDEAL LIFE Inc. and home care agency Bayada Nurses Inc. said today hospitalizations for patients using IDEAL LIFE’s remote health management products for congestive heart failure (CHF) and hypertension decreased 40 to 60 percent since the program began in September 2007.

June 2, 2009 - Cordex Pharma Inc. said today the FDA cleared the design of pivotal, phase 2b/3 clinical trials evaluating its lead product ATPace as an antiarrhytmic drug for the acute treatment of patients with paroxysmal supraventricular tachycardia (PSVT) under the special protocol assessment (SPA) process.

June 1, 2009 - Devax Inc. today said FDA has conditionally approved an investigational device exemption (IDE) for its AXXESS Biolimus A9-Eluting Bifurcation Stent System, allowing the company to initiate a pivotal clinical trial (DIVERGE II) of the device in the U.S.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now